Evidence map›Paper›PMID 26375494›Full record

ArticleBritish journal of pharmacology2015

Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat.

J L Barr, B A Rasmussen, C S Tallarida, J L Scholl, G L Forster, E M Unterwald, S M Rawls

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

J L BarrDepartment of Pharmacology and Centre for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA, USA.
B A RasmussenDepartment of Pharmacology and Centre for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA, USA.
C S TallaridaDepartment of Pharmacology and Centre for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA, USA.
J L SchollCentre for Brain and Behaviour Research, Division of Basic Biomedical Sciences, Sanford School of Medicine at the University of South Dakota, Vermillion, SD, USA.
G L ForsterCentre for Brain and Behaviour Research, Division of Basic Biomedical Sciences, Sanford School of Medicine at the University of South Dakota, Vermillion, SD, USA.
E M UnterwaldDepartment of Pharmacology and Centre for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA, USA.
S M RawlsDepartment of Pharmacology and Centre for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA, USA.
Temple University · USUniversity of South Dakota · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Anjali M Rajadhyaksha · 2000 to 2026
$34.6M
TRAINING PROGRAM: DRUGS OF ABUSE RELATED NEUROPEPTIDEST32DA007237 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ELLEN M UNTERWALD · 1988 to 2026
$10.6M
Neural Sensitivity to Stress During Drug WithdrawalR01DA019921 · NIDA · UNIVERSITY OF SOUTH DAKOTA · PI FORSTER, GINA L · 2005 to 2015
$2.4M
Clavulanic acid: a potential abuse-deterrent and CNS-active therapeuticR21DA030676 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI RAWLS, SCOTT M. · 2011 to 2012
$421k
NIDA NIH HHS P30 DA013429NIDA NIH HHS R01 DA019921NIDA NIH HHS R21 DA030676NIDA NIH HHS T32 DA007237
6 · The paper itself

Abstract

background and purposeCeftriaxone is a β-lactam antibiotic and glutamate transporter activator that reduces the reinforcing effects of psychostimulants. Ceftriaxone also reduces locomotor activation following acute psychostimulant exposure, suggesting that alterations in dopamine transmission in the nucleus accumbens contribute to its mechanism of action. In the present studies we tested the hypothesis that pretreatment with ceftriaxone disrupts acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens. EXPERIMENTAL APPROACH: Adult male Sprague-Dawley rats were pretreated with saline or ceftriaxone (200 mg kg(-1) , i.p. × 10 days) and then challenged with cocaine (15 mg kg(-1) , i.p.). Motor activity, dopamine efflux (via in vivo microdialysis) and protein levels of tyrosine hydroxylase (TH), the dopamine transporter and organic cation transporter as well as α-synuclein, Akt and GSK3β were analysed in the nucleus accumbens. KEY

resultsCeftriaxone-pretreated rats challenged with cocaine displayed reduced locomotor activity and accumbal dopamine efflux compared with saline-pretreated controls challenged with cocaine. The reduction in cocaine-evoked dopamine levels was not counteracted by excitatory amino acid transporter 2 blockade in the nucleus accumbens. Pretreatment with ceftriaxone increased Akt/GSK3β signalling in the nucleus accumbens and reduced levels of dopamine transporter, TH and phosphorylated α-synuclein, indicating that ceftriaxone affects numerous proteins involved in dopaminergic transmission. CONCLUSIONS AND IMPLICATIONS: These results are the first evidence that ceftriaxone affects cocaine-evoked dopaminergic transmission, in addition to its well-described effects on glutamate, and suggest that its ability to attenuate cocaine-induced behaviours, such as psychomotor activity, is due in part to reduced dopaminergic neurotransmission in the nucleus accumbens.

Indexed as

AnimalsCeftriaxoneCocaineDopamineGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaMaleMotor ActivityNucleus AccumbensProto-Oncogene Proteins c-aktRats, Sprague-DawleySynaptic TransmissionCeftriaxoneCocaineDopamineGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, ratProto-Oncogene Proteins c-akt

Identifiers

PMID26375494
PMCPMC4950793
OpenAlexW1825179960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.